PERSPECTA

News from every angle

← Back to headlines

Biogen Receives Approval for Subcutaneous Leqembi Initiation Dose

Biogen has secured approval for a subcutaneous version of its drug Leqembi, specifically for the initiation dose, marking a new development in its administration.

13 Jul, 22:56 — 13 Jul, 22:56
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed46d ago

Biogen nabs approval of subcutaneous version of Leqembi for initiation dose

Read full article →

Related Stories

48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room

2h ago

Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy

2h ago

Study Reveals Hidden Arterial Calcification in Young Adults

4h ago

Two German Airport Workers Die of Malaria Contracted on Flight

12h ago